CLINICAL_TRIALS
trial_result
· 2017-05-05
Clinical Trial Update: Memantine and Cognitive Dysfunction in Bipolar Disorder [Phase 4]
Summary
Phase 4 clinical trial investigating memantine for cognitive dysfunction in bipolar disorder has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-05-05